Valley National Advisers Inc Cardiol Therapeutics Inc. Transaction History
Valley National Advisers Inc
- $662 Million
- Q1 2024
A detailed history of Valley National Advisers Inc transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Valley National Advisers Inc holds 5,000 shares of CRDL stock, worth $9,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,000
Previous 5,000
-0.0%
Holding current value
$9,600
Previous $4,000
125.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRDL
# of Institutions
38Shares Held
6.55MCall Options Held
71.7KPut Options Held
0-
Mmcap International Inc. Spc Grand Cayman, E92.57MShares$4.93 Million0.7% of portfolio
-
Tejara Capital LTD London, X01.64MShares$3.16 Million1.09% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.3MShares$2.5 Million0.41% of portfolio
-
Lion Street Advisors, LLC193KShares$369,9840.13% of portfolio
-
Cambridge Investment Research Advisors, Inc.129KShares$247,1860.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $119M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...